Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | egl-9 family hypoxia-inducible factor 1 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_131326 | All targets in OG5_131326 |
Neospora caninum | 2OG-Fe(II) oxygenase family protein, putative | Get druggable targets OG5_131326 | All targets in OG5_131326 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | 2OG-Fe(II) oxygenase superfamily, putative | 0.0017 | 0.0013 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0022 | 0.0174 | 0.0174 |
Onchocerca volvulus | 0.0017 | 0.0013 | 0.5 | |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.002 | 0.0105 | 0.0112 |
Echinococcus multilocularis | roundabout 2 | 0.0022 | 0.0174 | 0.0213 |
Trypanosoma cruzi | 2OG-Fe(II) oxygenase superfamily, putative | 0.0017 | 0.0013 | 0.5 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0022 | 0.0174 | 0.0197 |
Echinococcus multilocularis | prolyl 4 hydroxylase subunit alpha 1 | 0.0017 | 0.0013 | 0.0016 |
Toxoplasma gondii | oxidoreductase, 2OG-Fe(II) oxygenase family protein | 0.0017 | 0.0013 | 0.5 |
Toxoplasma gondii | oxidoreductase, 2OG-Fe(II) oxygenase family protein | 0.0017 | 0.0013 | 0.5 |
Echinococcus granulosus | roundabout 2 | 0.0022 | 0.0174 | 0.0213 |
Loa Loa (eye worm) | prolyl 4-hydroxylase 2 | 0.0017 | 0.0013 | 0.0013 |
Loa Loa (eye worm) | hypothetical protein | 0.025 | 0.8086 | 0.8086 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0013 | 0.0013 |
Brugia malayi | hypothetical protein | 0.0022 | 0.0174 | 0.0197 |
Leishmania major | hypothetical protein, unknown function | 0.0017 | 0.0013 | 0.5 |
Schistosoma mansoni | prolyl 4-hydroxylase alpha subunit 1 | 0.0017 | 0.0013 | 0.0767 |
Echinococcus multilocularis | tyrosine protein kinase | 0.0253 | 0.8191 | 1 |
Trypanosoma brucei | 2OG-Fe(II) oxygenase superfamily, putative | 0.0017 | 0.0013 | 0.5 |
Toxoplasma gondii | tetratricopeptide repeat-containing protein | 0.0017 | 0.0013 | 0.5 |
Echinococcus granulosus | prolyl 4 hydroxylase subunit alpha 1 | 0.0017 | 0.0013 | 0.0016 |
Loa Loa (eye worm) | TK protein kinase | 0.0253 | 0.8191 | 0.8191 |
Leishmania major | hypothetical protein, conserved | 0.0017 | 0.0013 | 0.5 |
Brugia malayi | Protein kinase domain containing protein | 0.0253 | 0.8191 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0022 | 0.0174 | 0.0174 |
Schistosoma mansoni | cell adhesion molecule | 0.0022 | 0.0174 | 1 |
Echinococcus granulosus | tyrosine protein kinase | 0.0253 | 0.8191 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0022 | 0.0174 | 0.0174 |
Schistosoma mansoni | nephrin | 0.0022 | 0.0174 | 1 |
Brugia malayi | Fibronectin type III domain containing protein | 0.0022 | 0.0174 | 0.0197 |
Toxoplasma gondii | hypoxia- inducible factor prolyl hydroxylase (phd2), putative | 0.0017 | 0.0013 | 0.5 |
Loa Loa (eye worm) | TK/KIN16 protein kinase | 0.002 | 0.0105 | 0.0105 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (binding) | Inhibition of PHD2 in human Hep3B cells assessed as increase in erythropoietin secretion at 50 uM after 24 hrs by ELISA | ChEMBL. | 24894560 | |
IC50 (binding) | = 3.4 uM | Inhibition of PHD2 in human Hep3B cells assessed as erythropoietin secretion by ELISA | ChEMBL. | 24894560 |
Inhibition (binding) | Inhibition of PHD2 in human Hep3B cells assessed as increase in erythropoietin secretion at 100 uM after 24 hrs by ELISA | ChEMBL. | 24894560 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.